Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Dealing

9th Jul 2025 17:14

RNS Number : 4320Q
Imaging Biometrics Limited
09 July 2025
 

Imaging Biometrics Limited

("IB" or the "Company")

 

PDMR dealing

 

Imaging Biometrics Limited, a leader in quantitative imaging solutions and novel therapies for CNS malignancies, announces that it has been notified of the following transactions in ordinary shares in the Company undertaken by directors/persons discharging managerial responsibility (PDMR).

 

The notification below is made in accordance with Article 19(3) of the Market Abuse Regulation.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 Michael Schmainda

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

 

a)

 

Name

 

 

Imaging Biometrics, Ltd

b)

 

LEI

 

 

213800SPW48XRJS2QH57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each in Imaging Biometrics, Ltd

Identification code

JE00BD4H0R42

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

0.7 pence

200,000 Ordinary Shares

d)

 

Aggregated information

- Aggregated volume

200,000

- Price

£1400

e)

 

Date of the transaction

 

 

09/07/2025

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKXNEFASEFA

Related Shares:

Imaging Bio
FTSE 100 Latest
Value9,177.24
Change12.01